ICHR

ANALYST NOTE: ICHOR HOLDINGS, LTD. (ICHR) DATE: 2026-06-13 SUBJECT: Structural Breakout Confirmation in AI-Driven Semicap Supply Chain

1. Structural Readiness

Conservative Entry: $24.65 Current Price: $98.61 Extension: +300.0% vs. conservative entry Volatility Context:

• ATR at Breakout: 5.3% (High) — Indicates strong structural quality and conviction at the time of the initial move.
• Current ATR: 6.8% (Very High) — Elevated volatility today suggests active participation and potential for continued momentum, though it requires careful position sizing.

2. Thesis Layer

Primary Secular Thesis: AI Infrastructure → Semicap Equipment & Materials (Tier Direct, High Confidence). Secondary Secular Thesis: Reshoring & Industrial Automation → Semiconductor Onshoring (Tier Direct, High Confidence).

Conviction Weighting: ICHR is positioned as a direct beneficiary of the AI infrastructure build-out. The company provides critical fluid delivery subsystems essential for the etch and deposition processes required by advanced logic nodes (Gate-All-Around architectures). The dual exposure to AI Infrastructure and Onshoring creates a compounded tailwind: the former drives the volume of advanced nodes, while the latter drives the geographic diversification and capacity expansion of the fabs themselves. The evidence suggests the company is not merely a peripheral supplier but a "tier direct" participant in the most capital-intensive segments of the semiconductor value chain.

3. Business Overview

Business Model & Industry: Ichor Holdings, Ltd. designs, engineers, and manufactures critical fluid delivery subsystems and components. The company operates primarily in the Semiconductor Capital Equipment sector, with secondary exposure to Defense/Aerospace and Medical industries.

• Core Products: Gas delivery subsystems (monitoring and controlling specialized gases for etch/deposition) and chemical delivery subsystems (blending/dispensing reactive liquid chemistries for CMP, electroplating, and cleaning).
• Customer Base: The company sells directly and through resellers to Original Equipment Manufacturers (OEMs). Key relationships include Lam Research, Applied Materials, and ASML, which were the largest customers by sales in 2025.
• Geographic Footprint: Production facilities are located in California, Minnesota, Oregon, Texas, Singapore, Malaysia, and Mexico, supporting a global supply chain.

Supporting Evidence (As of 2026-06-13):

• Revenue Growth: Q1 2026 net sales reached $256.1 million, up from $244.5 million in the prior year period. Full-year 2025 revenue was $947.7 million, up from $849.0 million in 2024.
• Management Guidance (Q2 2026): In the May 4, 2026 earnings transcript, management guided Q2 revenues to approximately $300 million (±$10 million), representing a sequential improvement.
• Margin Expansion: Management expects gross margins to expand by approximately 100 basis points per quarter through the second half of 2026, driven by factory utilization and the completion of transitions. Q2 gross margin is expected to be in the 13% to 14% range.
• Process Complexity: Management highlighted that leading-edge logic with Gate-All-Around architectures requires a 30% increase in process steps, directly increasing the demand for Ichor's precision fluid delivery systems.

4. Archetype and Conviction

Archetype: Growth Leader Rationale: The company fits the "Growth Leader" archetype due to its ability to capture secular demand through a steep ramp in revenue and margin expansion. The evidence points to a "steepest ramp witnessed in Ichor's history," with growth well over 30% in just two quarters.

Valuation & Conviction Stack:

• Thesis Strength: High. The company is a direct play on the AI-driven expansion of etch and deposition capacity.
• Evidence Quality: Strong. The financial spine shows complete coverage with forward consensus EPS of $1.38 (FY1) and $2.70 (FY2). Management guidance is specific and backed by historical performance.
• Structural Quality: High. The ATR at breakout (5.3%) was in the "high" bucket, indicating a robust move. The current ATR (6.8%) is "very high," suggesting the stock is in a high-velocity phase.
• Rerating Potential: Significant. The combination of margin expansion (100 bps/quarter) and revenue acceleration suggests a potential multiple expansion as the market recognizes the sustainability of the growth ramp.

5. Invalidation, Strengthening, and Gaps

Invalidation Triggers:

• Fundamental Deterioration: A miss on the Q2 guidance of $300 million or a failure to deliver the expected 100 bps margin expansion would challenge the "Growth Leader" thesis.
• Customer Concentration: Any material disruption in relationships with Lam Research or Applied Materials (who accounted for 76% of 2025 sales) would be a critical risk.

Strengthening Factors:

• Continued Margin Expansion: If Q2 gross margins exceed the 14% upper bound of the guidance range, it would validate the efficiency gains from the restructuring.
• Capacity Utilization: Further confirmation of "unconstrained demand" exceeding $300 million in subsequent quarters would reinforce the secular thesis.

Evidence Gaps:

• No Missing Evidence: The evidence base is complete as of the event date.
• Customer Concentration Risk: While the evidence confirms the top two customers account for 76% of sales, there is no specific evidence in the provided block detailing the diversification strategy or the status of the remaining 24% of the customer base. This is a structural risk inherent in the business model that is not fully mitigated by the current data.

PRIVATE ANALYST CALL

Judgment: Strong Buy Confidence: High Key risks: Extreme customer concentration (76% of sales from two OEMs); very high current ATR (6.8%) indicating elevated volatility; potential for margin expansion to stall if factory utilization does not meet expectations. Sizing hint: Position size should account for the very high current ATR; consider scaling in on volatility dips rather than chasing the full extension. Expected path: Management expects continued sequential revenue growth and margin expansion through the second half of 2026 as capacity transitions complete; structural demand for fluid delivery in advanced nodes remains robust. Expected horizon: 12 to 18 months for the full realization of the margin expansion and revenue ramp.